Data-driven Healthcare Transformations

First of its kind, all-inclusive cardio-pulmonary platform for seamless and high-quality remote care across healthcare’s care continuum ​
US FDA 510(k) Cleared
CE Approved Medical Device
US Patented
Australia's Therapeutic Goods Administration (TGA) Approved
HIPAA & US FDA Cybersecurity ​Certified
ISO 13485 QMS ​Certified

Why Respiree?

icon detection

Days in Advance Deterioration Detection with >90% Accuracy

icon dashboards

End-to-End Secured EHR Dashboards

icon biomarker

Decentralized Clinical Trials Platform with Digital Biomarker Development

Solutions Trusted by Partners and Patients:​

Respiree Care

End-to-end enterprise-connected remote-care solution across healthcare’s care continuum, from hospital-at-home, to chronic disease management to rehabilitation​

Respiree OneBio

Integrating more than 1000s of pulmonary-cardio multi-modal biomarkers on a decentralized clinical trials platform with clinically validated software

Trusted by leading healthcare systems, medical technology companies, biopharma and patients​

Awards

President's Technology Award 2024

ATS 2022 RIS Featured Start-up ​

Falling Walls Finalist 2022

Top 50 Southeast Asia Health Tech Startup in 2022

HealthTech 250 - Most promising Early-stage Ventures in 2022 Digital Health​